Synthesis and in vitro proof-of-concept studies on bispecific iron oxide magnetic nanoparticles targeting PSMA and GRP receptors for PET/MR imaging of prostate cancer-Reference-Cited by-同舟云学术

Synthesis and in vitro proof-of-concept studies on bispecific iron oxide magnetic nanoparticles targeting PSMA and GRP receptors for PET/MR imaging of prostate cancer

Published:2022-08 Issue: Volume:624 Page:122008
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Liolios Christos,Koutsikou Theodora S.,Salvanou Evangelia-Alexandra,Kapiris Fotis,Machairas Evangelos,Stampolaki Marianna,Kolocouris Antonios,Efthimiadou Eleni Κ.,Bouziotis Penelope

Funder

European Commission

European Social Fund

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference61 articles.

1. Impact of long-term androgen deprivation therapy on PSMA ligand PET/CT in patients with castration-sensitive prostate cancer;Afshar-Oromieh;Eur. J. Nucl. Med. Mol. Imaging,2018

2. Improving the Imaging Contrast of68Ga-PSMA-11 by Targeted Linker Design: Charged Spacer Moieties Enhance the Pharmacokinetic Properties;Baranski;Bioconjug. Chem.,2017

3. Linker Modification Strategies To Control the Prostate-Specific Membrane Antigen (PSMA)-Targeting and Pharmacokinetic Properties of DOTA-Conjugated PSMA Inhibitors;Benešová;J. Med. Chem.,2016

4. Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer;Benešová;J Nucl Med,2015

5. PET/CT imaging and radioimmunotherapy of prostate cancer;Bouchelouche;Semin. Nucl. Med.,2011

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances in Metal Oxide and Phosphate Nanomaterials Radiolabeling with Medicinal Nuclides;ACS Omega;2024-09-12

2. The Current Status and Future Directions on Nanoparticles for Tumor Molecular Imaging;International Journal of Nanomedicine;2024-09

3. Advancements in Iron Oxide Nanoparticles for Multimodal Imaging and Tumor Theranostics;Current Medicinal Chemistry;2024-07-12

4. Targeting prostate cancer by new bispecific monocyte engager directed to prostate-specific membrane antigen;2024-07-08

5. The use of PET/MRI in radiotherapy;Insights into Imaging;2024-02-27